InvestorNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Launches withZeta.ai Platform, Opens New Revenue Stream
Lantern Pharma (NASDAQ: LTRN) announced the commercial launch of withZeta.ai, its multi-agentic AI co-scientist platform for rare cancer drug discovery, with subscriptions now available across academic and commercial tiers, creating a new non-dilutive revenue stream for the company. The platform, built from Lantern’s RADR (R) oncology-focused AI technologies, will be showcased at a private investor event at Nasdaq MarketSite in New York on April 16, 2026,…